Sign in
Taking people in GermanyPhase 1

PLX-PAD cell injections into the knee for mild to moderate osteoarthritis

Tests the safety of PLX-PAD cell injections in people with knee osteoarthritis.

Key facts

Who runs it
Charite Universitaetsmedizin Berlin KöR
Where
Berlin, GermanySee the site
Trial code
Registry title
A phase I, prospective, mono-center, double-blinded, randomized, controlled study to assess the safety and tolerability of intraarticular injection of PLX-PAD cells for the treatment of mild to moderate knee osteoarthritis – PROTO–I
Status
Recruiting
Phase
Phase 1
People taking part
18 people, planned
Started
25 Aug 2026
Planned end
15 Nov 2026
Type of study
Interventional
Record updated
21 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with mild to moderate knee osteoarthritis. It tests the safety of PLX-PAD cells injected into the knee joint.

Age
18 Years and older
Sex
All sexes can join
Disease stage
Mild to moderate knee osteoarthritis

Main reasons for not taking part

  • Healthy volunteers cannot join

Where in Germany

  • Charite Universitaetsmedizin Berlin KöRBerlin, GermanyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Plain-language title
PLX-PAD cell injections into the knee for mild to moderate osteoarthritisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
21 July 2026